GACCI, MAURO
 Distribuzione geografica
Continente #
EU - Europa 16.881
NA - Nord America 10.659
AS - Asia 3.414
SA - Sud America 38
AF - Africa 25
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.036
Nazione #
US - Stati Uniti d'America 10.596
PL - Polonia 6.433
IT - Italia 4.385
RU - Federazione Russa 2.955
HK - Hong Kong 1.707
IE - Irlanda 943
SE - Svezia 706
CN - Cina 617
CH - Svizzera 477
SG - Singapore 399
IN - India 322
FI - Finlandia 309
GB - Regno Unito 152
DE - Germania 146
VN - Vietnam 125
FR - Francia 117
JO - Giordania 108
UA - Ucraina 91
TR - Turchia 59
CA - Canada 54
ES - Italia 44
BR - Brasile 27
NL - Olanda 26
KR - Corea 21
AT - Austria 16
BE - Belgio 16
AU - Australia 15
EG - Egitto 13
RO - Romania 12
GR - Grecia 11
RS - Serbia 11
IR - Iran 10
LT - Lituania 8
PK - Pakistan 8
JP - Giappone 7
TW - Taiwan 6
BG - Bulgaria 5
DM - Dominica 5
PE - Perù 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
IQ - Iraq 4
AL - Albania 3
KH - Cambogia 3
MK - Macedonia 3
MX - Messico 3
PH - Filippine 3
ZA - Sudafrica 3
DK - Danimarca 2
EU - Europa 2
MM - Myanmar 2
MT - Malta 2
MU - Mauritius 2
NG - Nigeria 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
SM - San Marino 1
TZ - Tanzania 1
Totale 31.036
Città #
Warsaw 6.428
Fairfield 1.650
Hong Kong 1.177
Ashburn 1.152
Dublin 943
Chandler 795
Woodbridge 789
Seattle 764
Houston 675
Cambridge 610
Wilmington 551
Bern 448
Milan 319
Mumbai 275
Lawrence 256
Singapore 252
Rome 248
Ann Arbor 243
Princeton 238
Altamura 235
Moscow 233
Florence 222
Beijing 192
West Jordan 187
Helsinki 172
Jacksonville 153
Medford 134
Boardman 127
Shanghai 118
Boston 107
San Diego 101
Dong Ket 98
New York 98
Buffalo 91
Turin 70
Hillsboro 67
Naples 67
Falls Church 60
Kent 52
Bologna 49
Washington 46
Los Angeles 44
Palermo 40
Catania 39
Norwalk 39
Padova 39
Izmir 34
Bari 33
Verona 31
Phoenix 29
Barcelona 27
Genoa 27
Guangzhou 27
Ottawa 27
Santa Clara 26
Redwood City 25
Brescia 24
Napoli 24
Dearborn 23
Parma 22
Andover 21
Trieste 21
London 20
Perugia 20
Salerno 20
Toronto 18
Bergamo 17
Messina 17
Pescara 16
Pune 16
Torino 16
Vienna 16
Ancona 13
Hangzhou 13
Brussels 12
Monza 12
Bremen 11
Chernivtsi 11
Pisa 11
Rui'an 11
Seoul 11
Arezzo 10
Cagliari 10
Cosenza 10
Modena 10
Nanjing 10
Prato 10
Ravenna 10
Redmond 10
São Paulo 10
Camparada 9
Caserta 9
Cinisello Balsamo 9
Detroit 9
Shenzhen 9
Tappahannock 9
Wuhan 9
Frankfurt am Main 8
Imola 8
Siena 8
Totale 21.572
Nome #
VALIDAZIONE E ANALISI COMPARATIVA DEGLI INDICI NEFROMETRICI PADUA, RENAL, C-INDEX E DAP COME PREDITTORI DEGLI OUTCOMES PERIOPERATORI E FUNZIONALI DOPO NEFRECTOMIA PARZIALE ROBOTICA 1.076
RUOLO PROGNOSTICO ED ETIOPATOGENESI DELLA NECROSI ISTOLOGICA COAGULATIVA NEL CARCINOMA RENALE A CELLULE CHIARE NON METASTATICO 1.066
CONFRONTO TRA PROSTATECTOMIA RADICALE NERVE-SPARING BILATERALE EFFETTUATA CON TECNICA ROBOTICA ANTEROGRADA ED OPEN ANTEROGRADA: RISULTATI DI UN SINGOLO CENTRO AD ALTO VOLUME CHIRURGICO 996
PROSTATECTOMIA RADICALE A CIELO APERTO ANTEROGRADA VS. RETROGRADA PER ETP PROSTATA IN CASI AD ALTO RISCHIO: ANALISI DEI MARGINI CHIRURGICI IN SETTECENTO PAZIENTI TRATTATI IN CENTRI DI RIFERIMENTO TERZIARI 551
ENUCLEAZIONE SEMPLICE PER IL TRATTAMENTO DI TUMORI RENALI AD ALTA COMPLESSITà CHIRURGICA: RISULTATI PERIOPERATORI, ONCOLOGICI E FUNZIONALI. 381
CLAMP VS CLAMPLESS ENDOSCOPIC ROBOT-ASSISTED SIMPLE ENUCLEATION (ERASE) FOR THE TREATMENT OF CLINICAL T1 RENAL MASSES: ANALYSIS OF SURGICAL AND FUNCTIONAL OUTCOMES FROM A MATCHED-PAIRED COMPARISON. 257
Endoscopic robot-assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results. 250
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 246
Nocturia related to post radiation bladder pain can be improved by hyaluronic acid chondroitin sulfate (ialuril®) 242
ENDOSCOPIC ROBOT-ASSISTED SIMPLE ENUCLEATION (ERASE) VS OPEN SIMPLE ENUCLEATION (OSE) FOR THE TREATMENT OF CLINICAL T1 RENAL MASSES: ANALYSIS OF PREDICTORS OF TRIFECTA OUTCOME 238
Quality of Life and Sexual Health in the Aging of PCa Survivors. 236
The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms. 234
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative 231
ANALYSIS OF SURGICAL COMPLICATIONS OF RENAL TUMOR ENUCLEATION WITH STANDARDIZED INSTRUMENTS AND EX- TERNAL VALIDATION OF PADUA CLASSIFICATION 229
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 228
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. 220
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 220
PSA kinetics parameters are predictive of PET features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 216
Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. 215
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 215
The prediction of the trifecta outcome from clinical variables in patients candidates to partial nephrectomy for t1 renal tumors 214
PSA KINETICS PARAMETERS ARE PREDICTIVE OF PET FEATURES WORSENING IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER PROSTATE CANCER TREATMENT WITH RADICAL INTENT: RESULTS FROM A LONGITUDINAL COHORT STUDY 212
INVERTED PAPILLOMA OF THE KIDNEY: A SYSTEMATIC REVIEW OF LITERATURE 211
ENDOSCOPIC ROBOT-ASSISTED SIMPLE ENUCLEATION (ERASE) VS. OPEN SIMPLE ENUCLEATION (OSE) FOR THE TREATMENT OF CLINICAL T1 RENAL MASSES: ANALYSIS OF PREDICTORS OF TRIFECTA OUTCOME 209
Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. 209
SIMPLE ENUCLEATION FOR THE TREATMENT OF HIGHLY COMPLEx RENAL TUMORS: PERIOPERATIVE, FUNCTIONAL AND ONCOLOGICAL RESULTS. 208
Effectiveness and Safety of Oro-Dispersible Sildenafil in a New Film Formulation for the Treatment of Erectile Dysfunction: Comparison Between Sildenafil 100-mg Film-Coated Tablet and 75-mg Oro-Dispersible Film. 208
Robotic-assisted versus open partial nephrectomy: A prospective multicenter comparison study of perioperative outcomes (AGILE project) 201
CONFRONTO DEI RISULTATI ONCOLOGICI E DELLE COMPLICANZE PERIOPERATORIE TRA PROSTATECTOMIA OPEN E ROBOTICA: MATCHED PAIR ANALYSIS SU MILLE PROCEDURE ANTEROGRADE EFFETTUATE IN UN SINGOLO CENTRO AD ALTO VOLUME. 200
SYSTEMATIC REVIEW OF PENILE METASTASES: ANALYSIS OF THE RESULTS OF THE LAST 10 YEARS 199
Effectiveness of highly purified urofollitropin treatment in patients with idiopathic azoospermia before testicular sperm extraction. 198
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 196
CURRENT STATUS OF SIMPLE ENUCLEATION IN THE SCENARIO OF NEPHRON-SPARING SURGERY: A SYSTEMATIC REVIEW OF THE LITERATURE 195
Enucleazione tumorale robot-assistita (rate) per il trattamento delle masse renali: consiDerazioni tecniche e risultati preliminari 191
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 191
RUOLO DEI FATTORI DI RISCHIO METABOLICI NEL RECUPERO FUNZIONALE DOPO PROSTATECTOMIA RADICALE ROBOTICA: DATI PRELIMINARI DI UN SINGOLO CENTRO 189
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 187
ROBOT-ASSISTED ENUCLEATIVE PARTIAL NEPHRECTOMY FOR HIGHLY COMPLEX RENAL MASSES 186
PERIOPERATIVE OUTCOMES OF ROBOTIC VERSUS OPEN SIMPLE ENUCLEATION FOR THE TREATMENT OF T1A-T1B RENAL CELL CARCINOMA. A SINGLE CENTER MATCHED-PAIR COMPARISON. 186
The impact of prior TURP on radical prostatectomy surgical margins: A multicenter analysis and members of the mirror study, LUNA foundation 183
EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) 182
PATHOLOGICAL OUTCOMES IN PATIENTS CANDIDABLE FOR ACTIVE SURVEILLANCE TREATED WITH RADICAL PROSTATECTOMY. ARE THEY REALLY LOW RISK PATIENTS? 180
ROBOTIC-ASSISTED SIMPLE ENUCLEATION FOR THE TREATMENT OF CLINICAL T1 RENAL MASSES: SINGLE-CENTER EXPERIENCE 174
Neovescica ileale ortotopica secondo Camey II: modificazioni tecniche mediane impiego di suturatrici meccaniche 173
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 168
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 167
VOIDING SYMPTOMS, INCLUDING BLADDER PAIN, RELATED TO POST RADIATION TREATMENT FOR PCA ARE IMPROVED BY IALURIL®: A PROSPECTIVE OBSERVATIONAL STUDY 167
Robotic Versus Open Simple Enucleation for the Treatment of T1a-T1b Renal Cell Carcinoma: A Single Center Matched-pair Comparison 166
Uso dell'androtest per lo screening dell'ipogonadismo in pazienti con ETP prostata in attesa di prostatectomia 165
OPEN VERSUS ROBOTIC-ASSISTED PARTIAL NEPHRECTOMY: MULTICENTER COMPARATIVE STUDY OF SURGICAL RESULTS AND COMPLICATIONS (AGILE GROUP) 164
Meta-analysis of metabolic syndrome and prostate cancer 164
MONOLATERAL NERVE-SPARING PROSTATECTOMY: REVIEW OF INDICATIONS, FUNCTIONAL AND ONCOLOGIC OUTCOME 161
Testicular sperm extraction after laparoscopic orchiectomy for bilateral postpubertal intra-abdominal cryptorchidism: What chance of sperm retrieval? 161
Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study 154
Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study 146
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 144
Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion 140
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. 135
Regeneration of Glomerular Podocytes by Human Renal Progenitors. 132
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 127
Tolterodine extended release in the treatment of male oab/storage luts: A systematic review 126
External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. 122
Reappraising the microscopic anatomy of human testis: identification of telocyte networks in the peritubular and intertubular stromal space 115
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 115
Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base 114
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 113
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 113
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 112
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 107
278 Sexual Lifestyle in Male and Females Medical Students: Results of an Italian Survey 107
Quality of life in patients with bladder cancer undergoing ileal conduit: A comparison of women versus men 107
Imperative indications for conservative surgery for renal cell carcinoma: 20 years' experience. 106
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 106
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 105
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 104
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys 104
Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: results of a randomized, double blind, placebo-controlled pilot study. 103
Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. 102
Benign prostatic hyperplasia: a new metabolic disease? 102
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 102
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 101
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. 101
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 99
Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study. 97
Late relapse in testicular germ cell tumors. 97
Persistance of storage luts after Greenlight™ prostate laser therapy: Not only a matter of technique 96
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 95
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 94
Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot Study. 93
Renal cell carcinoma metastatic to the breast and breast cancer metastatic to the kidney: two rare solitary metastases. 93
Healing of spongiosus-cutaneous fistula with Hyperbaric Oxygen Therapy (HBOT): a case report 92
Androgen deprivation therapy in prostate cancer: focusing on sexual side effects 92
The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction. 92
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 91
The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways. 91
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 90
Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors. 90
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome 90
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. 90
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 89
Totale 18.748
Categoria #
all - tutte 111.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.287 0 0 175 362 659 553 517 625 481 345 450 120
2020/20213.691 278 347 145 455 231 333 375 328 347 449 174 229
2021/20221.739 77 153 187 67 77 91 105 127 84 93 212 466
2022/20235.092 374 680 219 273 283 710 499 295 443 497 235 584
2023/20245.578 162 236 855 315 375 693 262 1.479 150 511 288 252
2024/20254.339 1.179 2.833 327 0 0 0 0 0 0 0 0 0
Totale 31.829